Understanding Rheumatoid Arthritis Medications: Types, Uses, and Side Effects

Rheumatoid Arthritis (RA) is a chronic inflammatory disorder affecting the joints and connective tissue. Managing RA often involves a variety of medications, each with specific uses and potential side effects.

DMARDs (Disease-Modifying Antirheumatic Drugs) and NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) are common treatments for RA. DMARDs, such as leflunomide, help slow disease progression, while NSAIDs alleviate pain and inflammation. However, it’s important to be aware of the risks associated with these drugs. For instance, leflunomide should be stopped before conception due to potential risks, and drugs like Xeljanz and Olumiant may increase the risk of serious infections, cancers, and lymphoma.

Patients also use pain medications to manage RA symptoms. Celecoxib (Celebrex) is an example, available in strengths of 50 mg, 100 mg, 200 mg, and 400 mg. While effective in reducing pain, swelling, and inflammation, long-term use of Celebrex is not recommended due to associated risks.

Alternative treatments, like fish oil supplements, have shown promise in reducing RA pain and stiffness, though side effects like nausea and a fishy taste in the mouth are possible.

Rheumatism, encompassing over 200 conditions including arthritis, involves chronic pain in joints and tissues. Treatment options vary widely, ranging from acetaminophen and opioids to corticosteroids and immunosuppressants.

Rheumatology, a medical field focusing on these disorders, deals with the diagnosis and management of over 100 different diseases, including many forms of arthritis, lupus, and other inflammatory conditions.

For detailed information on RA medications, visit WebMD, Drugs.com, Verywell Health, Mayo Clinic, Wikipedia, and Healthline for comprehensive guides on RA medications.

Understanding Rheumatoid Arthritis Medications

See also  What Does Rheumatoid Arthritis Look Like? A Visual Guide to Symptoms and Effects

Leave a Reply

Your email address will not be published. Required fields are marked *